Assignee
ALTERGON SA
CH·38 granted patents·29 pending applications·102 citations·filing 1989–2024
Top patents by PatentIndex Score
67 records- 0187US11878030B2Ophthalmic formulations comprising cooperative complexes of low- and high-molecular-weight hyaluronic acidALTERGON SA·Filed 2021·Granted Jan 23, 2024·1 cites·4 claims
- 0281US11096913B2High-stability packaged solutions of T4 thyroid hormoneALTERGON SA·Filed 2019·Granted Aug 24, 2021·1 cites·9 claims
- 0380US7423028B2Injectable pharmaceutical compositions comprising sodium diclofenac and β-cyclodextrinALTERGON SA·Filed 2005·Granted Sep 9, 2008·7 cites·5 claims
- 0480US2025302787A1High-Stability Packaged Solutions of T4 Thyroid HormoneALTERGON SA·Filed 2024·Application pending·0 cites
- 0579US10206944B2Chondroitin for use in medicineALTERGON SA·Filed 2013·Granted Feb 19, 2019·5 cites·4 claims
- 0678US10537538B2High-stability packaged solutions of T4 thyroid hormoneALTERGON SA·Filed 2017·Granted Jan 21, 2020·3 cites·8 claims
- 0778US7723390B2Pharmaceutical formulations for thyroid hormonesALTERGON SA·Filed 2002·Granted May 25, 2010·22 cites·10 claims
- 0878US2023390233A1High-Stability Packaged Solutions of T4 Thyroid HormoneALTERGON SA·Filed 2023·Application pending·0 cites
- 0975US2023130290A1High-Stability Packaged Solutions of T4 Thyroid HormoneALTERGON SA·Filed 2022·Application pending·0 cites
- 1074US6592891B1Plaster for topical use containing heparin and diclofenacALTERGON SA·Filed 2000·Granted Jul 15, 2003·19 cites·9 claims
- 1174US2022280464A1Effects of Heparin on Topical Use of Plasters Containing a Non-Steroidal Anti-Inflammatory DrugALTERGON SA·Filed 2022·Application pending·0 cites
- 1274US2022287997A1Effects of Heparin on Topical Use of Plasters Containing a Non-Steroidal Anti-Inflammatory DrugALTERGON SA·Filed 2022·Application pending·0 cites
- 1373US9597282B2Cold-warm plasterALTERGON SA·Filed 2014·Granted Mar 21, 2017·3 cites·1 claims
- 1471US7691411B2Pharmaceutical formulae for thyroid hormones and procedures for obtaining themALTERGON SA·Filed 2003·Granted Apr 6, 2010·7 cites·32 claims
- 1571US5206262ASoluble salts of ibuprofen and naproxen with N-(2-hydroxyethyl) pyrrolidine and pharmaceutic compositions containing said saltsALTERGON SA·Filed 1992·Granted Apr 27, 1993·13 cites·8 claims
- 1670US10266611B2Hybrid cooperative complexes of hyaluronic acidALTERGON SA·Filed 2015·Granted Apr 23, 2019·1 cites·12 claims
- 1769US11344520B2Effects of heparin on topical use of plasters containing a non-steroidal anti-inflammatory drugALTERGON SA·Filed 2021·Granted May 31, 2022·0 cites·8 claims
- 1868US10646586B2Aqueous oral solutions of steroid hormones and hydroxypropyl-beta-cyclodextrin with optimised bioavailabilityALTERGON SA·Filed 2013·Granted May 12, 2020·2 cites·14 claims
- 1967US11351133B2Effects of heparin on topical use of plasters containing a non-steroidal anti-inflammatory drugALTERGON SA·Filed 2021·Granted Jun 7, 2022·0 cites·18 claims
- 2067US10857115B2Effects of heparin on topical use of plasters containing a non-steroidal anti-inflammatory drugALTERGON SA·Filed 2019·Granted Dec 8, 2020·0 cites·18 claims
- 2166US9168229B2Soft gelatin capsulesALTERGON SA·Filed 2014·Granted Oct 27, 2015·0 cites·5 claims
- 2266US2022233745A1Resorbable implantable device based on crosslinked glycosaminoglycans, and process for the preparation thereofALTERGON SA·Filed 2022·Application pending·0 cites
- 2365US10675270B2Chondroitin complexes for transcutaneous absorptionALTERGON SA·Filed 2018·Granted Jun 9, 2020·0 cites·5 claims
- 2463US12337022B2Use of a vegetable extract from salvia haenkei as an active agent in the treatment of heart diseasesALTERGON SA·Filed 2022·Granted Jun 24, 2025·0 cites·11 claims
- 2562US12404089B2Container for ampoules or syringesALTERGON SA·Filed 2022·Granted Sep 2, 2025·0 cites·9 claims
- 2662US2020246297A1Liquid pharmaceutical formulations of tetraiodothyronineALTERGON SA·Filed 2020·Application pending·0 cites
- 2762US2024277629A1Use of thyroid hormone t4 in a high versatility treatment in patients taking proton pump inhibitorsALTERGON SA·Filed 2022·Application pending·0 cites
- 2862US2018289650A1Liquid pharmaceutical formulations of tetraiodothyronineALTERGON SA·Filed 2018·Application pending·0 cites
- 2959US2024156725A1Solid orodispersible pharmaceutical composition in film containing lorazepamALTERGON SA·Filed 2022·Application pending·0 cites
- 3058US2015174258A1Chondroitin complexes for transcutaneous absorptionALTERGON SA·Filed 2013·Application pending·0 cites
- 3157US10842883B2Aqueous oral solutions of steroid hormones and hydroxypropyl-β-cyclodextrin with optimised bioavailabilityALTERGON SA·Filed 2020·Granted Nov 24, 2020·0 cites·8 claims
- 3257US2024285711A1Use of a vegetal extract from salvia haenkei as an active agent in the treatment of a musculoskeletal disorderALTERGON SA·Filed 2022·Application pending·0 cites
- 3356US2017105955A1Liquid pharmaceutical formulations of tetraiodothyronineALTERGON SA·Filed 2016·Application pending·0 cites
- 3454US2023074099A1Injectable mixtures of hyaluronic acid for use in dermo-aestheticsALTERGON SA·Filed 2020·Application pending·0 cites
- 3554US2024000955A1Soluble polyelectrolyitic complexes of polymeric biguanidine microbiocides with glycosaminoglycansALTERGON SA·Filed 2021·Application pending·0 cites
- 3653US10905669B2Effects of heparin on topical use of plasters containing a non-steroidal anti-inflammatory drugALTERGON SA·Filed 2015·Granted Feb 2, 2021·0 cites·9 claims
- 3753US9314435B2Stable formulations of antiplatelet agents, omega-3 fatty acids and amylose in soft gelatin capsulesALTERGON SA·Filed 2012·Granted Apr 19, 2016·0 cites·9 claims
- 3851US11324854B2Resorbable implantable device based on crosslinked glycosaminoglycans, and process for the preparation thereofALTERGON SA·Filed 2018·Granted May 10, 2022·0 cites·9 claims
- 3951US2018221404A1Ophthalmic formulations comprising cooperative complexes of low- and high-molecular-weight hyaluronic acidALTERGON SA·Filed 2016·Application pending·0 cites
- 4049US2005142194A1Composition comprising CSALTERGON SA·Filed 2004·Application pending·0 cites
- 4148US7943668B2Process for preparing a pharmaceutical composition with anti-inflammatory and analgesic activity for administration via a patch for external use, and composition thus obtainedALTERGON SA·Filed 2008·Granted May 17, 2011·0 cites·4 claims
- 4247US12226549B2Synergistically cooperative compositions useful for soft tissue augmentation, drug delivery and related fieldsALTERGON SA·Filed 2019·Granted Feb 18, 2025·0 cites·14 claims
- 4347US11717486B2Highly stable formulations of thyroid hormone in soft capsulesALTERGON SA·Filed 2019·Granted Aug 8, 2023·0 cites·16 claims
- 4447US11090271B2Soft gelatin capsules containing hydroxypropyl beta cyclodextrin with high stabilityALTERGON SA·Filed 2018·Granted Aug 17, 2021·0 cites·9 claims
- 4547US6379695B1Betamethasone- and hyaluronic acid-treated thin adhesive plaster for the treatment of psoriasis dermatitis and dermatosisALTERGON SA·Filed 1999·Granted Apr 30, 2002·8 cites·11 claims
- 4646US12245989B2Plunger for a syringe-type pump for a machine for encapsulation of soft capsules, and syringe-type pump comprising one or more of said plungersALTERGON SA·Filed 2020·Granted Mar 11, 2025·0 cites·8 claims
- 4746US11235017B2Use of a vegetable extract as an active agent in the treatment of dermatological diseasesALTERGON SA·Filed 2018·Granted Feb 1, 2022·0 cites·10 claims
- 4846US11235016B2Use of a vegetal extract as an active agent in tissue re-epithelizing and cicatrizing processesALTERGON SA·Filed 2018·Granted Feb 1, 2022·0 cites·9 claims
- 4946US2006058262A1New injectable formulations containing progesteroneALTERGON SA·Filed 2005·Application pending·0 cites
- 5045US10251846B2Oral combination for the prevention and treatment of bladder, pelvic and urogenital apparatus pathologiesALTERGON SA·Filed 2014·Granted Apr 9, 2019·0 cites·6 claims
Showing the top 50 of 67 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →